Atlas Trials

High-dose Ribavirin in Treatment of Chronic Hepatitis C Genotype 1 or 4

Clinical trial NCT00662220 · TERMINATED

Trial details

NCT number
NCT00662220
Sponsor
Foundation for Liver Research
Status
TERMINATED
Phase
Phase 3
Study type
INTERVENTIONAL
Chronic Hepatitis C
Start date
2008-04-01
Primary completion
2013-06-01
Enrollment
110

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.